Evolutionary dynamics of cancer in response to targeted combination therapy
Ivana Božić(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Martin A. Nowak(Harvard University), Benjamin Allen(Boston University), Yo Sup Moon(Harvard College Observatory), Luis A. Díaz(Memorial Sloan Kettering Cancer Center), Krishnendu Chatterjee(Institute of Science and Technology Austria), Amin Yaqubie(Memorial Sloan Kettering Cancer Center), Tibor Antal(University of Edinburgh), Bert Vogelstein(Johns Hopkins University), Nicole Kelly(Memorial Sloan Kettering Cancer Center), Paul B. Chapman(Memorial Sloan Kettering Cancer Center), Preya Shah(Harvard College Observatory), Dung T. Le(Johns Hopkins University), Johannes G. Reiter(Institute of Science and Technology Austria), Evan J. Lipson(Bloomberg (United States))
Cited by 646
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k